Cargando…
Echinomycin as a promising therapeutic agent against KSHV-related malignancies
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiologic agent of several human cancers, including Kaposi’s sarcoma (KS) and primary effusion lymphoma (PEL), which preferentially arise in immunocompromised patients while lack of effective therapeutic options. Oncoproteins Myc and hypoxia-indu...
Autores principales: | Chen, Jungang, Lin, Zhen, Song, Jiao, Plaisance-Bonstaff, Karlie, James, Jennifer, Mu, Shengyu, Post, Steven R., Dai, Lu, Qin, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161613/ https://www.ncbi.nlm.nih.gov/pubmed/37143124 http://dx.doi.org/10.1186/s13045-023-01441-5 |
Ejemplares similares
-
Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis
por: Barrett, Lindsey, et al.
Publicado: (2020) -
Role of Histamine and Related Signaling in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis and Oncogenesis
por: Chen, Jungang, et al.
Publicado: (2023) -
Activation of IL1 signaling molecules by Kaposi’s sarcoma-associated herpesvirus
por: Chen, Jungang, et al.
Publicado: (2022) -
Sphingosine Kinase-2 Maintains Viral Latency and Survival for KSHV-Infected Endothelial Cells
por: Dai, Lu, et al.
Publicado: (2014) -
Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients
por: Dai, Lu, et al.
Publicado: (2022)